Skip to main content

Find Clinical Trials

Home
Conditions
Pathologic Complete Response

Clinical trial condition

Pathologic Complete Response

Explore clinical trials studying Pathologic Complete Response. Study availability and eligibility vary by location and protocol.

92 public trials 30 recruiting studies

Refine in advanced search Browse all conditions

Pathologic Complete Response trial results

Not Yet Recruiting

Avoiding Sentinel Lymph Node Biopsy in Breast Cancer Patients After Neoadjuvant Chemotherapy

NCT04225858

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +13 more
Locations: Not specified

View Trial Details

Completed

Clinical Utility of a PCR Compared to Culture and Sensitivity Testing for the Management of cUTI in Adults.

NCT06996301

Conditions: Disease, Disease Attributes, Disease Progression, +15 more
Locations: Silicon Valley Medical Development San Jose, California, United States

Albany Urology Clinic & Surgery Center Albany, Georgia, United States

Augusta Urology Associates Evans, Georgia, United States

Colquitt Regional Medical Center Moultrie, Georgia, United States

View Trial Details

Completed

Impact Of Metformin In Rectal Cancer Patients

NCT06728982

Conditions: Disease Attributes, Disease Progression, Pathologic Complete Response, +3 more
Locations: Minia Oncology Center Minya, Egypt

Minia University Hospital Minya, Egypt

View Trial Details

Completed

Efficacy of Oral Azacitidine Plus Best Supportive Care as Maintenance Therapy in Subjects With Acute Myeloid Leukemia (AML) in Complete Remission

NCT01757535

Conditions: Disease Attributes, Disease Progression, Hematologic Diseases, +9 more
Locations: Arizona Oncology Associates, P.C. Phoenix, Arizona, United States

Providence St Joseph Medical Center Cancer Center Burbank, California, United States

City Of Hope Duarte, California, United States

University of California San Francisco Fresno Campus Fresno, California, United States

View all 223 locations

View Trial Details

Completed

Intratumoral and Peritumoral Habitat Radiomics of MRI Predict Pathologic Complete Response to Neoadjuvant Chemoimmunotherapy in Oral Squamous Cell Carcinoma

NCT06854107

Conditions: Carcinoma, Carcinoma, Squamous Cell, Disease Attributes, +10 more
Locations: Hubei Cancer Hospitla Wuhan, Hubei, China

View Trial Details

Completed

Study on the Applicability of CCR Criteria in Rectal Cancer

NCT06794099

Conditions: Complete Response, Disease Attributes, Disease Progression, +6 more
Locations: Peking University Cancer Hospital & Institute Beijing, Beijing Municipality, China

View Trial Details

Completed

WT1 Vaccine Treatment of Patients in Remission From Acute Myeloid Leukemia (AML) or Acute Lymphoblastic Leukemia (ALL)

NCT01266083

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Disease Attributes, +17 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Completed

Pre-Operative Pembrolizumab + Chemoradiation in Patients With Locally Advanced Esophageal Squamous Cell Carcinoma

NCT04435197

Conditions: Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +17 more
Locations: Ruijin Hospital, Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China

Ruijin Hospital, Shanghai JiaoTong University School of Medicine Shanghai, Shanghai Municipality, China

View Trial Details

Completed

Neoadjuvant 5-fluorouracil, Epirubicin and Cyclophosphamide (FEC) Followed by Weekly Paclitaxel and Trastuzumab in Her2 Positive Breast Cancer

NCT01340430

Conditions: Disease Attributes, Disease Progression, HER-2 Positive Breast Cancer, +3 more
Locations: Istituto Nazionale per La Ricerca sul Cancro (IST) Genoa, Ge, Italy

Ospedale S. Maria della Misericordia - Oncologia Medica Perugia, PG, Italy

Fondazione del Piemonte per l'Oncologia - IRCC di Candiolo Candiolo, TO, Italy

Ospedale Ostetrico Ginecologico S. Anna Di Torino - Oncologia Medica Torino, To, Italy

View Trial Details

Completed

CCA of SGB PCR Versus SGB Culture at 35-38 SA in the Optimization of Intrapartum Antibiotic Prophylaxis

NCT05005169

Conditions: Disease Attributes, Disease Progression, Pathologic Complete Response, +3 more
Locations: Multon Nantes, Saint Herblain, France

Gillard Angers, France

Sentilhes Bordeaux, France

Houllier Le Kremlin-Bicêtre, France

View Trial Details